Insider Trading & Ownership - ARS Pharmaceuticals Inc. (SPRY)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for ARS Pharmaceuticals Inc.
Goto 0, 1, 2, 3, 4, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-11-25
Sale
2024-11-27
4:11 pm
ARS Pharmaceuticals Inc.SPRYChakma Justin
Chief Business Officer
100,000$14.12$1,411,742136,380
(Direct)
View
2024-11-19
Sale
2024-11-21
4:30 pm
ARS Pharmaceuticals Inc.SPRYLowenthal Richard E
PRESIDENT AND CEO
10% Owner
100,000$13.95$1,394,96010,218,153
(Indirect
Direct)
View
2024-11-19
Sale
2024-11-21
4:30 pm
ARS Pharmaceuticals Inc.SPRYTanimoto Sarina
CHIEF MEDICAL OFFICER
10% Owner
100,000$13.95$1,394,96010,218,153
(Indirect
Direct)
View
2024-11-12
Sale
2024-11-14
4:30 pm
ARS Pharmaceuticals Inc.SPRYTanimoto Sarina
CHIEF MEDICAL OFFICER
10% Owner
100,000$16.85$1,684,64210,369,106
(Indirect
Direct)
View
2024-11-12
Sale
2024-11-14
4:30 pm
ARS Pharmaceuticals Inc.SPRYLowenthal Richard E
PRESIDENT AND CEO
10% Owner
100,000$16.85$1,684,64210,369,106
(Indirect
Direct)
View
2024-11-11
Sale
2024-11-13
8:16 pm
ARS Pharmaceuticals Inc.SPRYFlynn James E
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Mgmt III L.P.
Deerfield Private Design Fund III L.P.
Deerfield Mgmt IV L.P.
Deerfield Private Design Fund IV L.P.
10% Owner
563,270$18.01$10,143,7065,257,328
(Indirect)
View
2024-10-16
Sale
2024-10-17
4:30 pm
ARS Pharmaceuticals Inc.SPRYScott Kathleen D.
Chief Financial Officer
12,500$16$200,000815,529
(Indirect
Direct)
View
2024-10-15
Sale
2024-10-17
4:30 pm
ARS Pharmaceuticals Inc.SPRYTanimoto Sarina
CHIEF MEDICAL OFFICER
10% Owner
100,000$14.88$1,487,59510,368,153
(Indirect
Direct)
View
2024-10-15
Sale
2024-10-17
4:30 pm
ARS Pharmaceuticals Inc.SPRYLowenthal Richard E
PRESIDENT AND CEO
10% Owner
100,000$14.88$1,487,59510,368,153
(Indirect
Direct)
View
2024-10-08
Sale
2024-10-10
4:28 pm
ARS Pharmaceuticals Inc.SPRYTanimoto Sarina
CHIEF MEDICAL OFFICER
10% Owner
100,000$13.83$1,382,77510,519,106
(Indirect
Direct)
View
2024-10-08
Sale
2024-10-10
4:27 pm
ARS Pharmaceuticals Inc.SPRYLowenthal Richard E
PRESIDENT AND CEO
10% Owner
100,000$13.83$1,382,77510,519,106
(Indirect
Direct)
View
2024-09-18
Sale
2024-09-19
4:30 pm
ARS Pharmaceuticals Inc.SPRYKaras Eric
Chief Commercial Officer
10,000$14$140,000600,281
(Direct)
View
2024-09-17
Sale
2024-09-19
4:29 pm
ARS Pharmaceuticals Inc.SPRYTanimoto Sarina
CHIEF MEDICAL OFFICER
10% Owner
100,000$12.93$1,293,20510,518,153
(Indirect
Direct)
View
2024-09-17
Sale
2024-09-19
4:26 pm
ARS Pharmaceuticals Inc.SPRYLowenthal Richard E
PRESIDENT AND CEO
10% Owner
100,000$12.93$1,293,20510,518,153
(Indirect
Direct)
View
2024-09-10
Sale
2024-09-12
4:25 pm
ARS Pharmaceuticals Inc.SPRYTanimoto Sarina
CHIEF MEDICAL OFFICER
10% Owner
100,000$11.5$1,149,77510,669,106
(Indirect
Direct)
View
2024-09-10
Sale
2024-09-12
4:24 pm
ARS Pharmaceuticals Inc.SPRYLowenthal Richard E
PRESIDENT AND CEO
10% Owner
100,000$11.5$1,149,77510,669,106
(Indirect
Direct)
View
2024-08-26
Sale
2024-08-28
4:30 pm
ARS Pharmaceuticals Inc.SPRYThompson Peter A.
Director
83,695$13$1,088,0358,288,510
(Indirect)
View
2024-08-26
Sale
2024-08-28
4:26 pm
ARS Pharmaceuticals Inc.SPRYORBIMED ADVISORS LLC
OrbiMed Capital GP VI LLC
ORBIMED CAPITAL LLC
Director
83,695$13$1,088,0358,288,510
(Indirect)
View
2024-08-21
Sale
2024-08-23
6:41 pm
ARS Pharmaceuticals Inc.SPRYThompson Peter A.
Director
868,682$13.24$11,497,9638,372,205
(Indirect)
View
2024-08-21
Sale
2024-08-23
6:38 pm
ARS Pharmaceuticals Inc.SPRYORBIMED ADVISORS LLC
OrbiMed Capital GP VI LLC
ORBIMED CAPITAL LLC
Director
868,682$13.24$11,497,9638,372,205
(Indirect)
View
2024-08-20
Sale
2024-08-21
6:51 pm
ARS Pharmaceuticals Inc.SPRYDorsey Brian
Chief Operating Officer
50,000$15$750,00067,852
(Direct)
View
2024-08-19
Sale
2024-08-21
6:51 pm
ARS Pharmaceuticals Inc.SPRYKaras Eric
Chief Commercial Officer
10,000$14$140,000610,281
(Direct)
View
2024-08-20
Sale
2024-08-21
6:49 pm
ARS Pharmaceuticals Inc.SPRYScott Kathleen D.
Chief Financial Officer
12,500$16$200,000828,029
(Direct)
View
2024-08-20
Sale
2024-08-21
6:48 pm
ARS Pharmaceuticals Inc.SPRYTanimoto Sarina
CHIEF MEDICAL OFFICER
10% Owner
100,000$15.03$1,502,58710,668,153
(Indirect
Direct)
View
2024-08-20
Sale
2024-08-21
6:47 pm
ARS Pharmaceuticals Inc.SPRYLowenthal Richard E
PRESIDENT AND CEO
10% Owner
100,000$15.03$1,502,58710,668,153
(Indirect
Direct)
View
2024-08-13
Sale
2024-08-15
4:30 pm
ARS Pharmaceuticals Inc.SPRYDorsey Brian
Chief Operating Officer
30,000$13$390,000117,852
(Direct)
View
2024-08-13
Sale
2024-08-15
4:30 pm
ARS Pharmaceuticals Inc.SPRYTanimoto Sarina
CHIEF MEDICAL OFFICER
10% Owner
100,000$12.48$1,247,55510,819,106
(Indirect
Direct)
View
2024-08-13
Sale
2024-08-15
4:30 pm
ARS Pharmaceuticals Inc.SPRYLowenthal Richard E
PRESIDENT AND CEO
10% Owner
100,000$12.48$1,247,55510,819,106
(Indirect
Direct)
View
2024-07-16
Sale
2024-07-18
4:30 pm
ARS Pharmaceuticals Inc.SPRYLowenthal Richard E
PRESIDENT AND CEO
10% Owner
100,000$11.4$1,140,29510,818,153
(Indirect
Direct)
View
2024-07-16
Sale
2024-07-18
4:30 pm
ARS Pharmaceuticals Inc.SPRYTanimoto Sarina
CHIEF MEDICAL OFFICER
10% Owner
100,000$11.4$1,140,29510,818,153
(Indirect
Direct)
View
2024-07-09
Sale
2024-07-11
5:04 pm
ARS Pharmaceuticals Inc.SPRYTanimoto Sarina
CHIEF MEDICAL OFFICER
10% Owner
100,000$9.6173$961,72510,969,106
(Indirect
Direct)
View
2024-07-09
Sale
2024-07-11
5:03 pm
ARS Pharmaceuticals Inc.SPRYLowenthal Richard E
PRESIDENT AND CEO
10% Owner
100,000$9.6173$961,72510,969,106
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-10-16
Exercise
2024-10-17
4:30 pm
N/A
2032-02-29
ARS Pharmaceuticals Inc.SPRYScott Kathleen D.
Chief Financial Officer
12,500$0815,529
(Direct)
View
2024-10-16
Exercise
2024-10-17
4:30 pm
N/A
N/A
ARS Pharmaceuticals Inc.SPRYScott Kathleen D.
Chief Financial Officer
12,500$1.5815,529
(Direct)
View
2024-09-18
Exercise
2024-09-19
4:30 pm
N/A
2032-05-23
ARS Pharmaceuticals Inc.SPRYKaras Eric
Chief Commercial Officer
10,000$0600,281
(Direct)
View
2024-09-18
Exercise
2024-09-19
4:30 pm
N/A
N/A
ARS Pharmaceuticals Inc.SPRYKaras Eric
Chief Commercial Officer
10,000$1.5600,281
(Direct)
View
2024-08-20
Exercise
2024-08-21
6:51 pm
N/A
2028-11-28
ARS Pharmaceuticals Inc.SPRYDorsey Brian
Chief Operating Officer
50,000$067,852
(Direct)
View
2024-08-20
Exercise
2024-08-21
6:51 pm
N/A
N/A
ARS Pharmaceuticals Inc.SPRYDorsey Brian
Chief Operating Officer
50,000$0.6467,852
(Direct)
View
2024-08-19
Exercise
2024-08-21
6:51 pm
N/A
2032-05-23
ARS Pharmaceuticals Inc.SPRYKaras Eric
Chief Commercial Officer
10,000$0610,281
(Direct)
View
2024-08-19
Exercise
2024-08-21
6:51 pm
N/A
N/A
ARS Pharmaceuticals Inc.SPRYKaras Eric
Chief Commercial Officer
10,000$1.5610,281
(Direct)
View
2024-08-20
Exercise
2024-08-21
6:49 pm
N/A
2032-02-29
ARS Pharmaceuticals Inc.SPRYScott Kathleen D.
Chief Financial Officer
12,500$0828,029
(Direct)
View
2024-08-20
Exercise
2024-08-21
6:49 pm
N/A
N/A
ARS Pharmaceuticals Inc.SPRYScott Kathleen D.
Chief Financial Officer
12,500$1.5828,029
(Direct)
View
2024-08-13
Exercise
2024-08-15
4:30 pm
N/A
2028-11-28
ARS Pharmaceuticals Inc.SPRYDorsey Brian
Chief Operating Officer
30,000$0117,852
(Direct)
View
2024-08-13
Exercise
2024-08-15
4:30 pm
N/A
N/A
ARS Pharmaceuticals Inc.SPRYDorsey Brian
Chief Operating Officer
30,000$0.64117,852
(Direct)
View
2024-06-20
Option Award
2024-06-24
5:13 pm
N/A
2034-06-19
ARS Pharmaceuticals Inc.SPRYRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
40,000$040,000
(Indirect)
View
2024-06-20
Option Award
2024-06-24
5:06 pm
N/A
2034-06-19
ARS Pharmaceuticals Inc.SPRYDadoo Rajeev
Director
40,000$040,000
(Direct)
View
2024-06-20
Option Award
2024-06-24
5:00 pm
N/A
2034-06-19
ARS Pharmaceuticals Inc.SPRYShawver Laura
Director
40,000$040,000
(Direct)
View
2024-06-20
Option Award
2024-06-24
5:00 pm
N/A
2034-06-19
ARS Pharmaceuticals Inc.SPRYShah Pratik
Director
40,000$040,000
(Direct)
View
2024-06-20
Option Award
2024-06-24
5:00 pm
N/A
2034-06-19
ARS Pharmaceuticals Inc.SPRYSCHNEIDER PHILLIP M
Director
40,000$040,000
(Direct)
View
2024-06-20
Option Award
2024-06-24
5:00 pm
N/A
2034-06-19
ARS Pharmaceuticals Inc.SPRYIslam Saqib
Director
40,000$040,000
(Direct)
View
2024-06-20
Option Award
2024-06-24
5:00 pm
N/A
2034-06-19
ARS Pharmaceuticals Inc.SPRYKelly Michael
Director
40,000$040,000
(Direct)
View
2024-06-20
Option Award
2024-06-24
5:00 pm
N/A
2034-06-19
ARS Pharmaceuticals Inc.SPRYThompson Peter A.
Director
40,000$040,000
(Direct)
View
Goto 0, 1, 2, 3, 4, Next